For instance, in HER-2 (human epidermal growth factor receptor-2 oncogene) expressing cells, in aggressive breast cancer models, HSF1 knockdown is accompanied by a specific down-regulation of HSP27 and HSP70 expression [63]. This evidence concerns the gene HSF1 and breast carcinoma.